RESEARCH UPDATES: Marinus, Ganaxolone and the TSC CALM Study скачать в хорошем качестве

RESEARCH UPDATES: Marinus, Ganaxolone and the TSC CALM Study

Presenter: Mary Kay Koenig, MD, Co-Director of the TSC Center of Excellence at McGovern Medical School, University of Texas Health Science Center at Houston Dr. Koenig provides an update from Marinus Pharmaceuticals about their TSC CALM study and how you can get involved. Their mission: passionately work to transform the lives of those living with tuberous sclerosis complex. The study is open to M/F ages 2-65 who experience seizures despite appropriate trial of two or more anti-seizure medications at therapeutic doses. This webinar was made possible by support from Marinus Pharmaceuticals.